JNCCN 360 – Bladder – ASTRO 2020: Bladder-Sparing Radiochemotherapy Regimens Under Study

By: Vanessa A. Carter, BS Posted: Monday, November 16, 2020 John J. Coen, MD, of 21st Century Oncology, Providence, Rhode Island, and colleagues conducted a phase II study to determine whether distant metastasis–free survival at 3 years would exceed a benchmark of 75% for two separate therapies. The treatments…

Read the full article here

Source: jnccn360.org
Categories: Hem/Onc News and Journals, Latest Headlines
Tags: , , ,
Tweets with this article
Journal of the @NCCN
#ASTRO20: Phase II study looks at survival rates from two separate #bladdercancer therapies: https://t.co/Ln0BWUxrE8 #blcsm #JNCCN360 https://t.co/2YpaT6PQsU

Related Articles